Study genetic risks in children with malignant brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 0 to 18 years old and has a confirmed malignant brain tumor
- The tumor type must be one of the listed types (like medulloblastoma, glioma, ependymoma, or others)
- Surgery to remove the tumor is planned, and your child is eligible to receive that resection
- Tumor diagnosis must be confirmed by the hospital’s pathology (microscope) review
- Your child has not had prior chemotherapy or radiation therapy (except steroids)
- There must be usable tumor tissue from surgery for genetic testing, and you agree to join and follow study visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how brain tumors (like high-risk gliomas, medulloblastoma, and ependymoma) respond to treatment and why they sometimes become resistant. It is for young people aged 15 to 39 and aims to use tumor tissue samples to understand the tumor better and guide future therapies.
This study tests a personalized treatment plan for children and young adults whose medulloblastoma or ependymoma has come back. It aims to guide doctors using new tissue from surgery or biopsy after earlier treatments are fully finished.
This Phase 2 trial tests how doctors choose treatment for infants and young children with newly diagnosed medulloblastoma, based on MRI/CSF staging and lab testing of the tumor. It may help by matching therapy intensity to the child’s specific risk level and tumor type.
This trial observes where medulloblastoma tumors first appear and how they grow during surgery. It helps doctors better understand these rare childhood and adult brain tumors.
This trial collects a small piece of tumor tissue during your planned surgery to grow it in the lab. This helps doctors learn more about childhood brain tumors and find better treatments.
This trial looks at a new way to treat a type of brain tumor called Group 3 medulloblastoma. Researchers want to understand how targeting a protein called MYC might help, and they will study tumor tissue from surgery.
Hear when a new Medulloblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.